Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cost-benefit analysis in mammography screening]

D von Fournier1

  • 1Abteilung Gyn. Radiologie, Radiologische Universitätsklinik Heidelberg.

Der Radiologe
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer.

British journal of cancer·2009
Same author

Dietary phytoestrogen intake and mammographic density -- results of a pilot study.

European journal of medical research·2005
Same author

Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study.

European journal of cancer (Oxford, England : 1990)·2004
Same author

A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery.

Cancer research·2001
Same author

[Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].

Zentralblatt fur Gynakologie·1999
Same author

Clinical experiences with direct magnification mammography with the DIMA Plus M11.

Zentralblatt fur Gynakologie·1999

Swedish Mammography-Screening trials demonstrate up to 30% mortality reduction in women aged 50-69. Long-term data show mammography screening is safe, with benefits for early breast cancer detection and treatment.

Area of Science:

  • Oncology
  • Radiology
  • Public Health

Context:

  • Swedish Mammography-Screening trials provide long-term data on screening efficacy.
  • Mammography screening involves a radiation dose of 2.4 mGy per breast for a 2-view examination.
  • Previous studies indicated a mortality reduction of up to 30% in women aged 50-69.

Purpose:

  • To evaluate the long-term effectiveness and safety of mammography screening.
  • To determine the impact of screening on breast cancer mortality rates and tumor characteristics.
  • To establish recommendations for quality-controlled mammography screening programs.

Summary:

  • Mammography screening significantly reduces breast cancer mortality by up to 30% in women aged 50-69.
  • Long-term observation (20 years) confirms no increased cancer risk from a 2.4 mGy radiation dose.

Related Experiment Videos

  • Screening leads to earlier diagnosis, less aggressive treatment, and smaller tumors compared to controls.

    • Impact:

    • Recommends quality-controlled screening in Germany for women aged 50-70.
    • Highlights the need for further trials to assess benefits for younger women (40-49).
    • Proposes a decentralized screening system involving general practitioners and hospitals, supported by quality assurance centers.